The Mystery of Jeffrey Epstein's Death

There's lots of stuff going on, a lot of biomarkers. We've already had a drug that slows it down by about 10, 20%. That was approved maybe 15 years ago. Well now they're starting to turn monoclonal antibodies towards ALS as well. So it's kind of in the same boat as Alzheimer's. There's some encouraging treatments, but it's still a long way.